In an Apoe−/− mouse model, the use of an anti-mouse PDCA1 antibody resulted in the depletion of pDCs in the aorta and spleen, leading to a significant reduction in atherosclerosis formation and a more stable plaque phenotype [122]. The gene discussed is APOE; the disease is atherosclerosis.